SFX by Ex Libris Inc.

Title:	JNK2 Is a Positive Regulator of the cJun Transcription Factor
Source:	Molecular Cell [1097-2765] Jaeschke, Anja yr:2006

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Turnbaugh, Peter J J. "An obesity-associated gut microbiome with increased capacity for energy harvest." Nature 444.7122 (2006): 1027-1031.
description	2.	KNIGHT, Zachary A. "Features of Selective Kinase Inhibitors." Chemistry & biology 12.6 (2005): 621-37.
description	3.	Tournier, C. "Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway." Science 288.5467 (2000): 870-4.
description	4.	Ordovas, José M M. "Identification of a functional polymorphism at the adipose fatty acid binding protein gene (FABP4) and demonstration of its association with cardiovascular disease: a path to follow." Nutrition Reviews 65.3 (2007): 130-4.
description	5.	Aggeli, Ioanna-Katerina S S. "Involvement of JNKs and p38-MAPK/MSK1 pathways in H2O2-induced upregulation of heme oxygenase-1 mRNA in H9c2 cells." Cellular signalling 18.10 (2006): 1801-1812.
description	6.	Ley Ruth E, Ruth E. "Microbial ecology: human gut microbes associated with obesity." Nature 444.7122 (2006): 1022-1023.
description	7.	Turnbaugh, Jeffrey J. "A core gut microbiome in obese and lean twins." Nature 457.7228 (2009): 480-4.
description	8.	Turnbaugh, Jeffrey J. "The core gut microbiome, energy balance, and obesity." The Journal of physiology 587.Pt 17 (2009): 4153-8.
description	9.	Ley, Ruth E E. "Obesity alters gut microbial ecology." Proceedings of the National Academy of Sciences of the United States of America 102.31 (2005): 11070-5.
description	10.	Vrieze, A. "Transfer of Intestinal Microbiota from Lean Donors Increases Insulin Sensitivity in Subjects with Metabolic Syndrome." Gastroenterology 143.4 (2012): 913-4294967295.
description	11.	ALAIMO, Peter J. "Targeting the gatekeeper residue in phosphoinositide 3-kinases." Bioorganic & medicinal chemistry 13.8 (2005): 2825-2836.
description	12.	Cohen, Michael S. "Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors." Science 308.5726 (2005): 1318-1321.
description	13.	Karaman, Mazen W. "A quantitative analysis of kinase inhibitor selectivity." Nature biotechnology 26.1 (2008): 127-32.
description	14.	Bajzer, M. "Physiology: obesity and gut flora." Nature 444.7122 (2007): 1009-10.
description	15.	Bäckhed, Fredrik, F. "The gut microbiota as an environmental factor that regulates fat storage." Proceedings of the National Academy of Sciences of the United States of America 101.44 (2004): 15718-15723.
description	16.	Muraski, John A. "Pim-1 regulates cardiomyocyte survival downstream of Akt." Nature medicine 13.12 (2007): 1467-75.
description	17.	Xu, C. "Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2." Molecular cancer therapeutics 5.8 (2006): 1918-1926.
description	18.	Heineke, J., Auger-Messier, M., Xu, J., Oka, T., S, J. "Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart." The journal of clinical investigation 117.11 (2007): 3198-3210.
description	19.	Fuite, Jim, J. "Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: An exploratory analysis." Genomics 92.6 (2008): 393-399.
description	20.	Tan, G D D. "The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes." Diabetologia 48.1 (2004): 83-95.